Subscribe to MDT Magazine News

Survey Reveals Roughly 3 in 5 Women May be Mistreating Their Yeast Infections

September 9, 2010 8:33 am | by Bio-Medicine.Org | Comments

SKILLMAN, N.J., Sept. 9 /- For more information, please go to: . Few women go through life having never suffered from the uncomfortable symptoms of a yeast infection.  In fact, nearly 3 in 4 (72 percent) women will experience their first...


Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences

September 9, 2010 8:33 am | by Bio-Medicine.Org | Comments

CRANBURY, N.J., Sept. 9 /- Cornerstone Pharmaceuticals, Inc., the cancer metabolism company, today announced that its CEO, Robert Shorr, Ph.D., D.I.C., will be speaking and Co-Chairing The Center for Business Intelligence's (CBI's) 4th Annual Oncology Clinical Trials Summit and chairing a...


Joint replacement: Does this look infected to you?

September 9, 2010 8:32 am | by EurekAlert | Comments

(American Academy of Orthopaedic Surgeons) Clinical practice guidelines are one avenue the AAOS uses to ensure that patients receive high quality care. A periprosthetic joint infection occurs when bacteria or other foreign organisms enter the wound during or at any point following joint...


2010 Prix Galien USA Pro Bono Humanum Award to be Presented to UNITAID for Work In Global HIV/AIDS Effort

September 9, 2010 8:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Sept. 9 /- The Prix Galien USA committee, responsible for awarding the most prestigious prize in biopharmaceutical research and development, today announced the 2010 winner of the Pro Bono Humanum Award for the 4th annual Prix Galien USA Awards competition. The award,...


Halozyme prices sale of 8.3M shares at $7.50 each

September 9, 2010 6:45 am | by The Associated Press | Comments

Halozyme Therapeutics Inc. said Thursday it priced an offering of 8.3 million shares of its stock at $7.50 per share.The underwriters of the offering will have an option to buy another 1.2 million shares to cover any overallotments.Shares of Halozyme closed at $7.99 Wednesday, making the price...

Federal Register: Determination of Regulatory Review Period for Purposes of Patent Extension; REPEL-CV

September 9, 2010 6:30 am | by U.S. Food & Drug Administration | Comments

The FDA has determined the regulatory review period for REPEL-CV and is publishing this notice of that determination as required by law.


3M acquires heating blanket maker for $810 million

September 9, 2010 5:45 am | by The Associated Press | Comments

Manufacturing conglomerate 3M Co. has agreed to pay $810 million for Arizant Inc., a company that makes heating devices for surgical patients.The deal announced Thursday is one of a string of recent acquisitions for 3M as it stretches beyond its traditional business of making Post-It Notes and...

BridgeHead Software and Dell Offer Holistic Storage and Data Management Specifically For Hospitals

September 9, 2010 5:31 am | by RealWire | Comments

Joint Medical Archive Solution Challenges Current Landscape of Healthcare Data ManagementAshtead, UK and Woburn, MA, USA - 9th September 2010 - BridgeHead Software and Dell are offering hospitals a new way to store their medical and administrative data: in a centralised repository, within...


Nottingham City Hospital Chooses Quality, Throughput and Flexibility With TomoTherapy(R) Radiation Therapy System for New Facility

September 9, 2010 4:45 am | by The Associated Press | Comments () —TomoTherapy Incorporated ( (NASDAQ: TOMO), maker of advanced, integrated radiation therapy solutions for cancer care, today announced that its technology will soon be used to treat cancer patients in Nottingham, England. The...


Use of medication for insomnia or anxiety increases mortality risk by 36 percent

September 9, 2010 12:31 am | by EurekAlert | Comments

(Université Laval) Taking medications to treat insomnia and anxiety increases mortality risk by 36 percent, according to a study conducted by Geneviève Belleville, a professor at Université Laval's School of Psychology. The details of this study are published in the latest edition of the...


SoloPower is first ever to receive UL certification for a flexible CIGS module

September 8, 2010 11:34 pm | by I-Micronews | Comments

Important Advancement for Solar Industry

Building an Implantable Artificial Kidney

September 8, 2010 9:35 pm | by Massachusetts Institute of Technology | Comments

A prototype uses kidney cells to help it perform vital functions.


Using chest compressions first just as successful as immediate defibrillation after cardiac arrest

September 8, 2010 9:34 pm | by EurekAlert | Comments

(University of Michigan Health System) In cardiac arrest, is it best to start pumping on the victim's chest or give an immediate shock to the heart? The University of Michigan learns both rescue strategies are effective, yet chest compressions before defibrillation may be best in events...


Abnormal body weight related to increased mortality in colon cancer patients

September 8, 2010 9:33 pm | by EurekAlert | Comments

(American Association for Cancer Research) Postmenopausal women diagnosed with colon cancer may be at increased risk of death if they fail to maintain a healthy body weight before cancer diagnosis, according to a study published in the September issue of Cancer Epidemiology, Biomarkers &...


ResMed says 2-for-1 stock split is complete

September 8, 2010 1:45 pm | by The Associated Press | Comments

Respiratory equipment maker ResMed Inc. confirmed Wednesday it completed a two-for-one stock split on Aug. 30.The split doubled the company's share count to nearly 151.4 million while halving the price of the shares. ResMed stock closed at $31.69 Wednesday, down 36 cents.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.